Yüklüyor......
A potential therapy for chordoma via antibody-dependent cell-mediated cytotoxicity (ADCC) employing NK or high affinity NK (haNK) cells in combination with cetuximab
OBJECTIVE: Chordoma is a rare bone tumor derived from the notochord, and is resistant to conventional therapies such as chemotherapy, radiotherapy, and targeting therapeutics. Expression of epidermal growth factor receptor (EGFR) in a large proportion of chordoma specimens indicates that chordoma ma...
Kaydedildi:
| Yayımlandı: | J Neurosurg |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6459012/ https://ncbi.nlm.nih.gov/pubmed/28753113 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3171/2017.1.JNS162610 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|